首页 > 最新文献

Endocrinology, diabetes and metabolism journal最新文献

英文 中文
Reversal of Early Increased Anxiety-Like Behavior in the Zucker Fatty versus Lean Rat: Possible Role of Acquired Hormonal Factors. 胖瘦大鼠早期增加的焦虑样行为的逆转:获得性激素因素的可能作用。
Pub Date : 2023-06-01 Epub Date: 2023-07-04 DOI: 10.31038/edmj.2023724
Mihal Grinberg, Mark B Zimering
{"title":"Reversal of Early Increased Anxiety-Like Behavior in the Zucker Fatty <i>versus</i> Lean Rat: Possible Role of Acquired Hormonal Factors.","authors":"Mihal Grinberg, Mark B Zimering","doi":"10.31038/edmj.2023724","DOIUrl":"10.31038/edmj.2023724","url":null,"abstract":"","PeriodicalId":72911,"journal":{"name":"Endocrinology, diabetes and metabolism journal","volume":"7 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478757/pdf/nihms-1919322.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10541257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperuricemia and the Severity of Coronavirus Disease 2019 in Japan: A Retrospective Cohort Study – An Inseparable Relation with Hypertension and Chronic Kidney Disease 高尿酸血症和2019年日本冠状病毒病的严重程度:一项回顾性队列研究-与高血压和慢性肾脏疾病密不可分的关系
Pub Date : 2023-05-22 DOI: 10.31038/edmj.2023721
Kaoru Yamashita, Satoshi Morimoto, Shihori Kimura, Yasufumi Seki, K. Bokuda, Daisuke Watanabe, M. Tsuji, Ken Arimura, K. Shimamoto, Etsuko Tagaya, Masatoshi Kawana, A. Ichihara
Introduction: This study aimed to explore the impact of comorbid hyperuricemia on disease severity in Japanese patients with coronavirus disease 2019 (COVID-19). This retrospective cohort study included patients with COVID-19 between July 2020 and February 2021. Methods: We divided patients into mild, moderate, and severe groups according to the degree of disease severity. Clinical and biochemical parameters on admission and comorbidities were compared between the mild and severe groups. Results: We enrolled 146 patients in this study: 36 patients were allocated to the mild group, 96 to the moderate group, and 14 to the severe group. The male sex, age, body mass index (BMI), systolic blood pressure, pulse rate, white blood cell counts, levels of serum urea nitrogen and uric acid were significantly higher in the severe group than in the mild group (p<0.05), while lymphocyte counts and estimated glomerular filtration rate were significantly lower (p<0.05). As for comorbidities, malignant tumor, diabetes mellitus, hypertension, chronic kidney disease (CKD), hyperlipidemia, and hyperuricemia were associated with COVID-19 severity. Logistic regression analysis indicated that hyperuricemia was significantly positively associated with the severity of COVID-19 independent of age, sex, BMI, comorbidities of diabetes mellitus, and malignant tumor. However, the association between hyperuricemia and COVID-19 severity was eliminated by correction with hypertension or CKD. Conclusion: These data suggested that comorbidities of hyperuricemia may indicate an increased risk of COVID-19 progression. Furthermore, patients with hyperuricemia comorbidities may require careful and intensive multidisciplinary treatment for hyperuricemia and hypertension and/or CKD to prevent progression of COVID-19.
简介:本研究旨在探讨日本2019冠状病毒病(新冠肺炎)患者合并高尿酸血症对疾病严重程度的影响。这项回顾性队列研究包括2020年7月至2021年2月期间的新冠肺炎患者。方法:根据疾病的严重程度将患者分为轻度、中度和重度三组。比较轻度和重度患者入院时的临床和生化参数以及合并症。结果:我们在本研究中招募了146名患者:36名患者被分配到轻度组,96名被分配到中度组,14名被分配给重度组。重度组的男性性别、年龄、体重指数(BMI)、收缩压、脉搏率、白细胞计数、血清尿素氮和尿酸水平显著高于轻度组(p<0.05),淋巴细胞计数和估计肾小球滤过率显著低于轻度组(p<0.05),慢性肾脏疾病(CKD)、高脂血症和高尿酸血症与新冠肺炎的严重程度相关。Logistic回归分析表明,高尿酸血症与新冠肺炎的严重程度显著正相关,与年龄、性别、BMI、糖尿病合并症和恶性肿瘤无关。然而,通过高血压或CKD的纠正,消除了高尿酸血症与新冠肺炎严重程度之间的关联。结论:这些数据表明,高尿酸血症的合并症可能表明新冠肺炎进展的风险增加。此外,患有高尿酸血症合并症的患者可能需要对高尿酸症、高血压和/或CKD进行仔细和强化的多学科治疗,以防止新冠肺炎的进展。
{"title":"Hyperuricemia and the Severity of Coronavirus Disease 2019 in Japan: A Retrospective Cohort Study – An Inseparable Relation with Hypertension and Chronic Kidney Disease","authors":"Kaoru Yamashita, Satoshi Morimoto, Shihori Kimura, Yasufumi Seki, K. Bokuda, Daisuke Watanabe, M. Tsuji, Ken Arimura, K. Shimamoto, Etsuko Tagaya, Masatoshi Kawana, A. Ichihara","doi":"10.31038/edmj.2023721","DOIUrl":"https://doi.org/10.31038/edmj.2023721","url":null,"abstract":"Introduction: This study aimed to explore the impact of comorbid hyperuricemia on disease severity in Japanese patients with coronavirus disease 2019 (COVID-19). This retrospective cohort study included patients with COVID-19 between July 2020 and February 2021. Methods: We divided patients into mild, moderate, and severe groups according to the degree of disease severity. Clinical and biochemical parameters on admission and comorbidities were compared between the mild and severe groups. Results: We enrolled 146 patients in this study: 36 patients were allocated to the mild group, 96 to the moderate group, and 14 to the severe group. The male sex, age, body mass index (BMI), systolic blood pressure, pulse rate, white blood cell counts, levels of serum urea nitrogen and uric acid were significantly higher in the severe group than in the mild group (p<0.05), while lymphocyte counts and estimated glomerular filtration rate were significantly lower (p<0.05). As for comorbidities, malignant tumor, diabetes mellitus, hypertension, chronic kidney disease (CKD), hyperlipidemia, and hyperuricemia were associated with COVID-19 severity. Logistic regression analysis indicated that hyperuricemia was significantly positively associated with the severity of COVID-19 independent of age, sex, BMI, comorbidities of diabetes mellitus, and malignant tumor. However, the association between hyperuricemia and COVID-19 severity was eliminated by correction with hypertension or CKD. Conclusion: These data suggested that comorbidities of hyperuricemia may indicate an increased risk of COVID-19 progression. Furthermore, patients with hyperuricemia comorbidities may require careful and intensive multidisciplinary treatment for hyperuricemia and hypertension and/or CKD to prevent progression of COVID-19.","PeriodicalId":72911,"journal":{"name":"Endocrinology, diabetes and metabolism journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42871192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Fulfilment of the Therapeutic Objectives in Type 2 Diabetes People Attended in Primary Care Centres in Northwest Spain 西班牙西北部初级保健中心2型糖尿病患者治疗目标实现情况的评估
Pub Date : 2023-05-22 DOI: 10.31038/edmj.2023714
{"title":"Evaluation of the Fulfilment of the Therapeutic Objectives in Type 2 Diabetes People Attended in Primary Care Centres in Northwest Spain","authors":"","doi":"10.31038/edmj.2023714","DOIUrl":"https://doi.org/10.31038/edmj.2023714","url":null,"abstract":"","PeriodicalId":72911,"journal":{"name":"Endocrinology, diabetes and metabolism journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48528689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empowering Young Researchers: Searching for What to Say to Young People to Avoid Becoming Obese 赋予年轻研究人员权力:寻找对年轻人说些什么来避免肥胖
Pub Date : 2023-05-08 DOI: 10.31038/edmj.2023713
71 US respondents, ages 14-19, evaluated phrases about what to do to avoid overeating. The phrases were selected by two student researchers, one in middle school, one in elementary school, using artificial intelligence. The phrases were combined according an underlying experimental design, creating 24 vignettes, with each of the 71 respondents evaluating a unique set of vignettes, rating each vignette on ‘for me versus not for me’. Clustering reveal three clearly different mind-sets about what is most relevant to the respondent; Mind-Set 1 focuses on exercise, Mind-Set 2 focuses on eating healthfully, Mind-Set 3 focuses on parental responsibility. The three mind-sets emerged clearly and dramatically, even though the respondents evaluated combinations of messages, some relevant, some not relevant.
{"title":"Empowering Young Researchers: Searching for What to Say to Young People to Avoid Becoming Obese","authors":"","doi":"10.31038/edmj.2023713","DOIUrl":"https://doi.org/10.31038/edmj.2023713","url":null,"abstract":"71 US respondents, ages 14-19, evaluated phrases about what to do to avoid overeating. The phrases were selected by two student researchers, one in middle school, one in elementary school, using artificial intelligence. The phrases were combined according an underlying experimental design, creating 24 vignettes, with each of the 71 respondents evaluating a unique set of vignettes, rating each vignette on ‘for me versus not for me’. Clustering reveal three clearly different mind-sets about what is most relevant to the respondent; Mind-Set 1 focuses on exercise, Mind-Set 2 focuses on eating healthfully, Mind-Set 3 focuses on parental responsibility. The three mind-sets emerged clearly and dramatically, even though the respondents evaluated combinations of messages, some relevant, some not relevant.","PeriodicalId":72911,"journal":{"name":"Endocrinology, diabetes and metabolism journal","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69508877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Fractures after Initiation of a Drug Holiday in a Real- Life Setting 在现实生活中开始药物假期后的骨折
Pub Date : 2023-04-05 DOI: 10.31038/edmj.2023712
Michael Morkos, Sanford Baim, Alessandra Casagrande, Paul Mahrous, Muriel Tania L Go, Hasan Husni, Mirette Hanna, Sara Bedrose, Dingfeng Li
Purpose: We aimed to assess the fracture rate in patients who were placed on a drug holiday (DH) after minimum adequate therapy versus those who continued therapy (CT) in a real-life setting. Methods: This is a retrospective cohort study conducted in a tertiary academic center. Inclusion criteria involved osteoporotic adults who received minimum adequate bisphosphonate therapy (≥ 3 years), otherwise, patients were excluded. Results: Of 1,814 charts randomly selected and reviewed, 272 patients met the inclusion criteria. In our cohort, females were 90.9%, White 50.0%, and African American 40.5%. A DH was initiated in 119 patients (43.8%). In the CT versus DH cohorts, the mean duration of therapy was 6.0 ± 2.6 versus 5.7 ± 2.3 years, total duration of follow-up 6.9 ± 2.9 versus 7.8 ± 2.7 years, and fractures occurred in 11.7% versus 9.2% respectively, not statistically different. The mean duration of follow-up after starting DH was 2.5 ± 1.9 years. Upon risk stratification using FRAX scoring, in the high-risk cohort, fragility fractures occurred in 16.5% (n=22/133) of the CT group versus 13.5% (n=7/52) of the DH cohort (P=0.66). In the lower risk cohort based on FRAX scoring, fragility fractures occurred in 7.1% (n=10/131) of the CT group versus 6.0% (n=4/63) of the DH cohort (P=1.0). Conclusion: In our cohort, continued drug therapy did not provide additional fracture protective benefits beyond the minimum adequate duration of therapy. A drug holiday after three to five years of treatment may be considered after review of risk factors for future fracture.
目的:我们的目的是评估在最低限度的适当治疗后被放置在药物假期(DH)的患者与在现实生活中继续治疗(CT)的患者的骨折率。方法:回顾性队列研究,在某高等学术中心进行。纳入标准为骨质疏松的成年人,接受最低限度的足量双膦酸盐治疗(≥3年),否则排除患者。结果:在随机选取的1814份病历中,有272例患者符合纳入标准。在我们的队列中,女性占90.9%,白人占50.0%,非裔美国人占40.5%。119例(43.8%)患者开始接受健康护理。CT组和DH组的平均治疗时间分别为6.0±2.6年和5.7±2.3年,总随访时间分别为6.9±2.9年和7.8±2.7年,骨折发生率分别为11.7%和9.2%,差异无统计学意义。开始DH后的平均随访时间为2.5±1.9年。在使用FRAX评分进行风险分层后,在高危队列中,CT组发生脆性骨折的比例为16.5% (n=22/133),而DH组为13.5% (n=7/52) (P=0.66)。在基于FRAX评分的低风险队列中,CT组脆性骨折发生率为7.1% (n=10/131),而DH组为6.0% (n=4/63) (P=1.0)。结论:在我们的队列中,持续的药物治疗并没有提供额外的骨折保护作用,超过了最小的适当治疗时间。在对未来骨折的危险因素进行评估后,可考虑在治疗3 - 5年后休药。
{"title":"Fractures after Initiation of a Drug Holiday in a Real- Life Setting","authors":"Michael Morkos, Sanford Baim, Alessandra Casagrande, Paul Mahrous, Muriel Tania L Go, Hasan Husni, Mirette Hanna, Sara Bedrose, Dingfeng Li","doi":"10.31038/edmj.2023712","DOIUrl":"https://doi.org/10.31038/edmj.2023712","url":null,"abstract":"Purpose: We aimed to assess the fracture rate in patients who were placed on a drug holiday (DH) after minimum adequate therapy versus those who continued therapy (CT) in a real-life setting. Methods: This is a retrospective cohort study conducted in a tertiary academic center. Inclusion criteria involved osteoporotic adults who received minimum adequate bisphosphonate therapy (≥ 3 years), otherwise, patients were excluded. Results: Of 1,814 charts randomly selected and reviewed, 272 patients met the inclusion criteria. In our cohort, females were 90.9%, White 50.0%, and African American 40.5%. A DH was initiated in 119 patients (43.8%). In the CT versus DH cohorts, the mean duration of therapy was 6.0 ± 2.6 versus 5.7 ± 2.3 years, total duration of follow-up 6.9 ± 2.9 versus 7.8 ± 2.7 years, and fractures occurred in 11.7% versus 9.2% respectively, not statistically different. The mean duration of follow-up after starting DH was 2.5 ± 1.9 years. Upon risk stratification using FRAX scoring, in the high-risk cohort, fragility fractures occurred in 16.5% (n=22/133) of the CT group versus 13.5% (n=7/52) of the DH cohort (P=0.66). In the lower risk cohort based on FRAX scoring, fragility fractures occurred in 7.1% (n=10/131) of the CT group versus 6.0% (n=4/63) of the DH cohort (P=1.0). Conclusion: In our cohort, continued drug therapy did not provide additional fracture protective benefits beyond the minimum adequate duration of therapy. A drug holiday after three to five years of treatment may be considered after review of risk factors for future fracture.","PeriodicalId":72911,"journal":{"name":"Endocrinology, diabetes and metabolism journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45696059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalance and Risk Factors of Hypogonadism in Male Patients with Type 2 Diabetes in El Minya, Egypt 埃及El Minya男性2型糖尿病患者性腺功能低下的患病率及危险因素
Pub Date : 2023-02-24 DOI: 10.31038/edmj.2023711
Background: Hypogonadism in adult men is a clinical and biochemical syndrome associated with low level of testosterone, which may adversely affect multiple organ functions and quality of life. It is closely related to the development of diabetes. This study was designed to determine the incidence of hypogonadism and related risk factors among men with type 2 diabetes (T2D). Patients and Methods: A total of 300 male patients diagnosed with T2D age from 30-70 years were enrolled in the study. Arabic version of the Androgen Deficiency in Aging Male (ADAM) questionnaire was employed to assess the androgen insufficiency in men. Hemoglobin A1c, FSH, LH, total and free testosterone, levels were measured by enzyme immunoassay. Results: T2D patients were divided into two groups: 48 (16%) patients with hypogonadism and 252 (84%) patients without hypogonadism. Multiple logistic regression analysis for factors affecting Hypogonadism among patients according to (total testosterone + ADAM +ve) versus those without hypogonadism it was found that age, random blood sugar, body mass index (BMI), Hb A1c are independent risk factors for the development of hypogonadism with odds ratio (0.95, 1, 1.1, 1.37) with p value (0.02, 0.03, 0. 03, 0.008) respectively. The ROC analysis of the accuracy of indices and cut off values for the studied total testosterone for predicting the hypogonadism according to total testosterone + ADAM score positive: The AUC was 0.98 «p-value <0.0001» with sensitivity 100% and specificity of 96.4% at Cut off value ≤ 12. Conclusion: Several risk factors of diabetes are associated closely with hypogonadism. Age, BMI, blood sugar, and Hb A1c are independent risk factors for the development of hypogonadism in male patients with T2D.
{"title":"Prevalance and Risk Factors of Hypogonadism in Male Patients with Type 2 Diabetes in El Minya, Egypt","authors":"","doi":"10.31038/edmj.2023711","DOIUrl":"https://doi.org/10.31038/edmj.2023711","url":null,"abstract":"Background: Hypogonadism in adult men is a clinical and biochemical syndrome associated with low level of testosterone, which may adversely affect multiple organ functions and quality of life. It is closely related to the development of diabetes. This study was designed to determine the incidence of hypogonadism and related risk factors among men with type 2 diabetes (T2D). Patients and Methods: A total of 300 male patients diagnosed with T2D age from 30-70 years were enrolled in the study. Arabic version of the Androgen Deficiency in Aging Male (ADAM) questionnaire was employed to assess the androgen insufficiency in men. Hemoglobin A1c, FSH, LH, total and free testosterone, levels were measured by enzyme immunoassay. Results: T2D patients were divided into two groups: 48 (16%) patients with hypogonadism and 252 (84%) patients without hypogonadism. Multiple logistic regression analysis for factors affecting Hypogonadism among patients according to (total testosterone + ADAM +ve) versus those without hypogonadism it was found that age, random blood sugar, body mass index (BMI), Hb A1c are independent risk factors for the development of hypogonadism with odds ratio (0.95, 1, 1.1, 1.37) with p value (0.02, 0.03, 0. 03, 0.008) respectively. The ROC analysis of the accuracy of indices and cut off values for the studied total testosterone for predicting the hypogonadism according to total testosterone + ADAM score positive: The AUC was 0.98 «p-value <0.0001» with sensitivity 100% and specificity of 96.4% at Cut off value ≤ 12. Conclusion: Several risk factors of diabetes are associated closely with hypogonadism. Age, BMI, blood sugar, and Hb A1c are independent risk factors for the development of hypogonadism in male patients with T2D.","PeriodicalId":72911,"journal":{"name":"Endocrinology, diabetes and metabolism journal","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42157354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge of Risks of Preeclampsia and Its Contributing Variables in Imo State 伊莫州对先兆子痫风险及其影响因素的认识
Pub Date : 2022-12-02 DOI: 10.31038/edmj.2022623
{"title":"Knowledge of Risks of Preeclampsia and Its Contributing Variables in Imo State","authors":"","doi":"10.31038/edmj.2022623","DOIUrl":"https://doi.org/10.31038/edmj.2022623","url":null,"abstract":"","PeriodicalId":72911,"journal":{"name":"Endocrinology, diabetes and metabolism journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47420948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myristolated Serotonin 2A Receptor Peptide Promotes Long-Lasting Blood Pressure-Lowering and Reno protection in Hypertensive Rat Species. 肉豆蔻化5 -羟色胺2A受体肽促进高血压大鼠持久降压和肾保护。
Pub Date : 2022-12-01 Epub Date: 2022-12-22 DOI: 10.31038/EDMJ.2022631
Mihal Grinberg, Mark B Zimering

Aim: The aim of the present study was to test whether conjugation of a synthetic peptide corresponding to a fragment of the second extracellular domain of the human serotonin 2A receptor substantially alters the in vivo pharmacodynamic blood pressure-lowering profile of the peptide in different hypertensive rat strains.

Methods: Sertuercept (SCLLADDN) was synthesized and modified using pegylation or myristolation. The two different peptide conjugates were tested in male Zucker diabetic fatty rats for acute and long-lasting blood pressure-lowering effects following single intraperitoneal administration. The myristolated Sertuercept was administered intraperitoneally to female Zucker fatty and male spontaneously hypertensive rats (SHR) and blood pressure was monitored either using tail cuff measurement (female Zucker) or by telemetry (SHR) rats. Plasma immunoglobulin G obtained by Protein G affinity chromatography in 25-week-old female Zucker or male spontaneously hypertensive rats was tested for binding to a linear synthetic peptide corresponding to the second extracellular loop of the serotonin 2A receptor. A cohort of male Zucker diabetic fatty rats was randomized to seven weeks of once-weekly myristolated Sertuercept or scrambled peptide (injections) and the kidneys were examined histologically for differences in total kidney lesions or fibrosis.

Results: Pegylated Sertuercept promoted substantial blood pressure-lowering lasting approximately 30-48 hours in male Zucker diabetic fatty rats. Blood pressure-lowering following a single injection of Myristolated Sertuercept was much longer-lasting (6-11 days) and it was effective in male Zucker diabetic fatty rats, male spontaneously hypertensive rats and in a subset of hypertensive female Zucker fatty rats. Seven weeks' treatment with once-weekly Myristolated Sertuercept (2mg/kg) was associated with significantly fewer kidney lesions and less interstitial fibrosis compared to scrambled peptide in 25-week-old male Zucker diabetic fatty rats. Male spontaneously hypertensive rats (4 of 4 tested) harbored plasma IgG which bound significantly to serotonin 2A receptor peptide, and a subset of female Zucker fatty rats harboring IgG were responsive to blood pressure-lowering from the myristolated Sertuercept peptide.

Summary: Myristolated-Sertuercept, an epitope-specific peptide comprised of a portion of second extracellular loop of the human serotonin 2A receptor was safe, well-tolerated and effectively lowered blood pressure for one week or longer in two different strains of male hypertensive rats. These data provide proof-of-concept that once-weekly systemic drug administration is feasible to achieve not only long-lasting hypertension control, but also substantial renoprotection.

目的:本研究的目的是测试与人类5 -羟色胺2A受体第二细胞外结构域片段相对应的合成肽的结合是否实质性地改变了不同高血压大鼠品系中肽的体内药效学降血压特征。方法:合成舒维西普(SCLLADDN),并进行聚乙二醇化或豆芽化修饰。两种不同的肽偶联物在雄性Zucker糖尿病脂肪大鼠中进行了单次腹腔注射后的急性和持久降压效果测试。分别给雌性Zucker脂肪肝大鼠和雄性自发性高血压大鼠(SHR)腹腔注射肉苁苁素,用尾袖测量法(雌性Zucker)和遥测法(SHR)监测血压。通过蛋白G亲和层分析法获得25周龄雌性Zucker或雄性自发性高血压大鼠的血浆免疫球蛋白G,检测其与血清素2A受体第二细胞外环对应的线性合成肽的结合。一组雄性Zucker糖尿病脂肪大鼠被随机分为七周,每周注射一次肉豆节塞普或混乱肽(注射),并对肾脏进行组织学检查,以观察肾脏总病变或纤维化的差异。结果:聚乙二醇化舒图西普促进了持续约30-48小时的雄性Zucker糖尿病脂肪大鼠的显著降压。单次注射肉豆蔻舒替西普后的降压效果更持久(6-11天),对雄性Zucker糖尿病脂肪大鼠、雄性自发性高血压大鼠和部分雌性高血压脂肪大鼠有效。在25周龄的雄性Zucker糖尿病脂肪大鼠中,与混乱肽相比,每周1次的肉豆醇化塞图西普(2mg/kg)治疗7周后,肾脏病变和间质纤维化明显减少。雄性自发性高血压大鼠(4 / 4)的血浆IgG与5 -羟色胺2A受体肽结合显著,而一小部分雌性Zucker脂肪大鼠的血浆IgG对多酚化Sertuercept肽降血压有反应。摘要:myristolate - sertuercept是一种表位特异性肽,由人5 -羟色胺2A受体第二细胞外环的一部分组成,在两种不同品系的雄性高血压大鼠中安全、耐受性良好,可有效降低血压一周或更长时间。这些数据提供了每周一次全身给药的概念证明,不仅可以实现持久的高血压控制,而且可以实现实质性的肾保护。
{"title":"Myristolated Serotonin 2A Receptor Peptide Promotes Long-Lasting Blood Pressure-Lowering and Reno protection in Hypertensive Rat Species.","authors":"Mihal Grinberg, Mark B Zimering","doi":"10.31038/EDMJ.2022631","DOIUrl":"10.31038/EDMJ.2022631","url":null,"abstract":"<p><strong>Aim: </strong>The aim of the present study was to test whether conjugation of a synthetic peptide corresponding to a fragment of the second extracellular domain of the human serotonin 2A receptor substantially alters the in vivo pharmacodynamic blood pressure-lowering profile of the peptide in different hypertensive rat strains.</p><p><strong>Methods: </strong>Sertuercept (SCLLADDN) was synthesized and modified using pegylation or myristolation. The two different peptide conjugates were tested in male Zucker diabetic fatty rats for acute and long-lasting blood pressure-lowering effects following single intraperitoneal administration. The myristolated Sertuercept was administered intraperitoneally to female Zucker fatty and male spontaneously hypertensive rats (SHR) and blood pressure was monitored either using tail cuff measurement (female Zucker) or by telemetry (SHR) rats. Plasma immunoglobulin G obtained by Protein G affinity chromatography in 25-week-old female Zucker or male spontaneously hypertensive rats was tested for binding to a linear synthetic peptide corresponding to the second extracellular loop of the serotonin 2A receptor. A cohort of male Zucker diabetic fatty rats was randomized to seven weeks of once-weekly myristolated Sertuercept or scrambled peptide (injections) and the kidneys were examined histologically for differences in total kidney lesions or fibrosis.</p><p><strong>Results: </strong>Pegylated Sertuercept promoted substantial blood pressure-lowering lasting approximately 30-48 hours in male Zucker diabetic fatty rats. Blood pressure-lowering following a single injection of Myristolated Sertuercept was much longer-lasting (6-11 days) and it was effective in male Zucker diabetic fatty rats, male spontaneously hypertensive rats and in a subset of hypertensive female Zucker fatty rats. Seven weeks' treatment with once-weekly Myristolated Sertuercept (2mg/kg) was associated with significantly fewer kidney lesions and less interstitial fibrosis compared to scrambled peptide in 25-week-old male Zucker diabetic fatty rats. Male spontaneously hypertensive rats (4 of 4 tested) harbored plasma IgG which bound significantly to serotonin 2A receptor peptide, and a subset of female Zucker fatty rats harboring IgG were responsive to blood pressure-lowering from the myristolated Sertuercept peptide.</p><p><strong>Summary: </strong>Myristolated-Sertuercept, an epitope-specific peptide comprised of a portion of second extracellular loop of the human serotonin 2A receptor was safe, well-tolerated and effectively lowered blood pressure for one week or longer in two different strains of male hypertensive rats. These data provide proof-of-concept that once-weekly systemic drug administration is feasible to achieve not only long-lasting hypertension control, but also substantial renoprotection.</p>","PeriodicalId":72911,"journal":{"name":"Endocrinology, diabetes and metabolism journal","volume":"6 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010125/pdf/nihms-1867880.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9116215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Tuberculosis in Patients Visiting Massawa Hospital: Cross-Sectional Study, 2021 Massawa医院就诊患者的结核病患病率:2021年横断面研究
Pub Date : 2022-11-30 DOI: 10.31038/edmj.2022622
Berhe Tesfai, Mihreteab Abraham, Hailemichael Gebremariam, Abiel Abraham, Liwam Abraham, Fitsum Kibreab
Background: Despite the availability of efficacious drugs, tuberculosis remains a major public health problem in low- and middle-income countries. This study was aimed to determine the prevalence of tuberculosis in Massawa Hospital, Eritrea. Methods: Laboratory and medical records of tuberculosis patients in Massawa Hospital were reviewed. All patients who did sputum exam by Xpert Gene from January 01, 2018 to May 1, 2021 in Massawa Hospital were enrolled in this study. Categorical variables were presented in percent, frequencies, Chi-square test, and odds ratio with 95% confidence interval. P value <0.05 was considered significant. Results: Sputum examination was done on 2178 patients and the prevalence of bacteriologically positive tuberculosis was 7%. Moreover, the prevalence of rifampicin resistant tuberculosis among the total tested and bacteriologically positive patients was 0.4% and 5.9% respectively. The main reason for sputum examination was presumptive diagnosis of tuberculosis (85.5%). Tuberculosis spondylitis (15.6%) and adenitis (13.6%) were found to be the most common types of extra pulmonary tuberculosis. The prevalence of tuberculosis in HIV patients was 5.2% and all started highly active antiretroviral therapy. Patients aged 15 to 24 years were having higher prevalence of tuberculosis (8.8%, 95%CI 0.68-4.72, OR-1.79). And, those from Ghelaelo subzone were having about two times higher prevalence of tuberculosis (9.9%, 95%CI 1.39-3.06, OR-2.06). Patients who had previous history of tuberculosis were having about five times higher prevalence of tuberculosis (27.5%, 95%CI 2.65-11.17. OR-5.4, p<0.001) and Rifampicin resistant tuberculosis (9.1%, p<0.002). Conclusion: The prevalence of tuberculosis and the multidrug resistant tuberculosis among the confirmed cases was comparatively increased than the average WHO estimates for Eritrea and similar to a study conducted in Nakfa subzone, Eritrea. The prevalence of tuberculosis in HIV patients was higher to the WHO estimates and previous studies in the country. Previous history of tuberculosis was significantly associated with the prevalence tuberculosis and multidrug resistant tuberculosis. Further prospective studies to evaluate the national prevalence of tuberculosis and rifampicin resistant tuberculosis are highly recommended.
背景:尽管有有效的药物,结核病仍然是中低收入国家的一个主要公共卫生问题。本研究旨在确定厄立特里亚马萨瓦医院的结核病患病率。方法:对马萨瓦医院肺结核病人的实验室及病历资料进行回顾性分析。2018年1月1日至2021年5月1日在马萨瓦医院接受Xpert Gene痰检的所有患者均纳入本研究。分类变量以百分比、频率、卡方检验和95%置信区间的比值比表示。P值<0.05被认为是显著的。结果:2178例患者进行了痰液检查,细菌阳性肺结核患病率为7%。此外,在全部检测和细菌阳性患者中,耐利福平结核病的患病率分别为0.4%和5.9%。痰检的主要原因是推定诊断为肺结核(85.5%),结核性脊柱炎(15.6%)和腺炎(13.6%)是最常见的肺外结核类型。艾滋病患者的结核病患病率为5.2%,所有患者都开始了高度积极的抗逆转录病毒治疗。15至24岁的患者结核病患病率较高(8.8%,95%CI0.68-4.72,OR-1.79)。来自Ghelaelo亚区的患者结核病发病率约高出两倍(9.9%,95%CI1.39-3.06,OR-2.06)。有结核病病史的患者结核病流行率约高5倍(27.5%,95%CI2.65-11.17)。OR-5.4,p<0.001)和利福平耐药结核病(9.1%,p<0.002)。艾滋病毒患者的结核病患病率高于世界卫生组织的估计和该国以前的研究。既往结核病史与结核病和耐多药结核病的患病率显著相关。强烈建议进行进一步的前瞻性研究,以评估全国结核病和耐利福平结核病的患病率。
{"title":"Prevalence of Tuberculosis in Patients Visiting Massawa Hospital: Cross-Sectional Study, 2021","authors":"Berhe Tesfai, Mihreteab Abraham, Hailemichael Gebremariam, Abiel Abraham, Liwam Abraham, Fitsum Kibreab","doi":"10.31038/edmj.2022622","DOIUrl":"https://doi.org/10.31038/edmj.2022622","url":null,"abstract":"Background: Despite the availability of efficacious drugs, tuberculosis remains a major public health problem in low- and middle-income countries. This study was aimed to determine the prevalence of tuberculosis in Massawa Hospital, Eritrea. Methods: Laboratory and medical records of tuberculosis patients in Massawa Hospital were reviewed. All patients who did sputum exam by Xpert Gene from January 01, 2018 to May 1, 2021 in Massawa Hospital were enrolled in this study. Categorical variables were presented in percent, frequencies, Chi-square test, and odds ratio with 95% confidence interval. P value <0.05 was considered significant. Results: Sputum examination was done on 2178 patients and the prevalence of bacteriologically positive tuberculosis was 7%. Moreover, the prevalence of rifampicin resistant tuberculosis among the total tested and bacteriologically positive patients was 0.4% and 5.9% respectively. The main reason for sputum examination was presumptive diagnosis of tuberculosis (85.5%). Tuberculosis spondylitis (15.6%) and adenitis (13.6%) were found to be the most common types of extra pulmonary tuberculosis. The prevalence of tuberculosis in HIV patients was 5.2% and all started highly active antiretroviral therapy. Patients aged 15 to 24 years were having higher prevalence of tuberculosis (8.8%, 95%CI 0.68-4.72, OR-1.79). And, those from Ghelaelo subzone were having about two times higher prevalence of tuberculosis (9.9%, 95%CI 1.39-3.06, OR-2.06). Patients who had previous history of tuberculosis were having about five times higher prevalence of tuberculosis (27.5%, 95%CI 2.65-11.17. OR-5.4, p<0.001) and Rifampicin resistant tuberculosis (9.1%, p<0.002). Conclusion: The prevalence of tuberculosis and the multidrug resistant tuberculosis among the confirmed cases was comparatively increased than the average WHO estimates for Eritrea and similar to a study conducted in Nakfa subzone, Eritrea. The prevalence of tuberculosis in HIV patients was higher to the WHO estimates and previous studies in the country. Previous history of tuberculosis was significantly associated with the prevalence tuberculosis and multidrug resistant tuberculosis. Further prospective studies to evaluate the national prevalence of tuberculosis and rifampicin resistant tuberculosis are highly recommended.","PeriodicalId":72911,"journal":{"name":"Endocrinology, diabetes and metabolism journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49546078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Susceptibility of South Asians to Cardiometabolic Disease as a Result of Starvation Adaptation Exacerbated During the Colonial Famines 殖民地饥荒期间饥饿适应加剧南亚人对心脏代谢疾病的易感性
Pub Date : 2022-10-07 DOI: 10.31038/edmj.2022621
M. Syed, F. Deek, A. Shaikh
South Asians, representing one quarter of the world’s population, have disproportionally high rates of obesity and cardiometabolic disease thus resulting an epidemic health crisis. This crisis could be the consequence of epigenetic effects exacerbated during the colonial-era famines resulting in a unique starvation-adapted physiology. Due to evolutionary mismatch in circumstances of abundance, this starvation-adapted physiology can become harmful. Evidence for this starvation adaptation in South Asians includes high body fat and unfavorable adipokines; low lean body mass; lower resting energy expenditure (compounded by lack of brown adipose tissue); greater insulin resistance and insulin response; exaggerated lipemic response to fat and sugar intake; less capacity to handle an overabundance of food; lower fat burning (oxidative capacity) and VO2max during aerobic exercise; and energy-conserving response to resistance exercise, as well as increased lipoprotein (a) levels. The Roma people, also of South Asian ancestry, may represent an interesting pre-colonial historical control. Physician and patient knowledge of this unique physiology in South Asians will promote a stronger physician-patient relationship and foster compliance with treatment.
南亚人占世界人口的四分之一,肥胖和心脏代谢疾病的发病率高得不成比例,从而导致了流行病健康危机。这场危机可能是殖民时代饥荒加剧的表观遗传效应的结果,饥荒导致了一种独特的适应饥饿的生理学。由于丰富环境中的进化不匹配,这种适应饥饿的生理机能可能会变得有害。南亚人这种饥饿适应的证据包括高体脂和不利的脂肪因子;低瘦体重;较低的静息能量消耗(棕色脂肪组织缺乏);更大的胰岛素抵抗和胰岛素反应;对脂肪和糖摄入的高脂血症反应;处理过量食物的能力较弱;在有氧运动中降低脂肪燃烧(氧化能力)和VO2max;以及对阻力运动的节能反应以及脂蛋白(a)水平的增加。同样具有南亚血统的罗姆人可能代表了一种有趣的殖民前历史控制。医生和患者对南亚人这种独特生理学的了解将促进更牢固的医患关系,并促进对治疗的依从性。
{"title":"The Susceptibility of South Asians to Cardiometabolic Disease as a Result of Starvation Adaptation Exacerbated During the Colonial Famines","authors":"M. Syed, F. Deek, A. Shaikh","doi":"10.31038/edmj.2022621","DOIUrl":"https://doi.org/10.31038/edmj.2022621","url":null,"abstract":"South Asians, representing one quarter of the world’s population, have disproportionally high rates of obesity and cardiometabolic disease thus resulting an epidemic health crisis. This crisis could be the consequence of epigenetic effects exacerbated during the colonial-era famines resulting in a unique starvation-adapted physiology. Due to evolutionary mismatch in circumstances of abundance, this starvation-adapted physiology can become harmful. Evidence for this starvation adaptation in South Asians includes high body fat and unfavorable adipokines; low lean body mass; lower resting energy expenditure (compounded by lack of brown adipose tissue); greater insulin resistance and insulin response; exaggerated lipemic response to fat and sugar intake; less capacity to handle an overabundance of food; lower fat burning (oxidative capacity) and VO2max during aerobic exercise; and energy-conserving response to resistance exercise, as well as increased lipoprotein (a) levels. The Roma people, also of South Asian ancestry, may represent an interesting pre-colonial historical control. Physician and patient knowledge of this unique physiology in South Asians will promote a stronger physician-patient relationship and foster compliance with treatment.","PeriodicalId":72911,"journal":{"name":"Endocrinology, diabetes and metabolism journal","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43879948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Endocrinology, diabetes and metabolism journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1